Strong execution capability is reflected in its quarterly results, the brokerage said, adding that the recent fundraising from GIC was followed by improved profitability. A balance sheet, healthy cash flows, and a strong overall performance remains key, MOSL said.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This